| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |